You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Early Diagnosis and the Need for Novel Therapeutics in ALS: Highlights from a Recent Symposium

  • Authors: Suma Babu, MBBS, MPH; Neil M. Thakur, PhD; Richard S. Bedlack, MD, PhD; Zachary Simmons, MD; Larry Falivena
  • CME / ABIM MOC Released: 10/20/2022
  • Valid for credit through: 10/20/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for neurologists, primary care physicians, physiatrists, otolaryngologists, orthopedists & orthopedic surgeons, nurse practitioners (NPs), and physician assistants (PAs) involved in the management of ALS.

The goal of this activity is that learners will be better able to recognize and diagnose ALS earlier and be better able to implement the optimal use of team-based care, as well as have better awareness of therapies in development for the management of ALS.

Upon completion of this activity, participants will have increased knowledge regarding the:

  • Factors that differentiate ALS from conditions with a similar presentation
  • Nature of the burden related to delayed diagnosis
  • Clinical data for investigational therapies for the treatment of ALS


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


  • Suma Babu, MBBS, MPH

    Assistant Professor of Neurology
    Massachusetts General Hospital
    Harvard Medical School
    Boston, Massachusetts


    Suma Babu, MBBS, MPH, has the following relevant financial relationships:
    Consultant or advisor for: AI Therapeutics
    Research funding from: AI Therapeutics; Biogen; Ionis; Medicinova; Novartis; Orion; Voyager


  • Neil M. Thakur, PhD

    Chief Mission Officer
    The ALS Association


    Neil M. Thakur, PhD, has no relevant financial relationships.


  • Richard S. Bedlack, MD, PhD

    Professor of Neurology
    Director of ALS Clinic
    Duke University
    Durham, North Carolina


    Richard S. Bedlack, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AB Science; ALSA; Alexion; Amylyx; Apellis; Biogen; Biohaven; Brainstorm; Clene; Corcept; Cytokinectics; GenieUS; Guidepoint; ITF Pharma; Mallinckrodt; Orphazyme; Shinkei; Woolsey
    Speaker or member of speakers bureau for: Amylyx
    Research funding from: Medicinova; Orion

  • Zachary Simmons, MD

    Professor and Vice-Chair for Research
    Department of Neurology
    Penn State College of Medicine
    Director, ALS Center
    Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania


    Zachary Simmons, MD, has the following relevant financial relationships:
    Consultant or advisor for: Alexion; Amylyx; Biogen; Biosensics; Cytokinetics
    Research funding from: MT Pharma

  • Larry Falivena

    Patient Advocate
    Board of Trustees
    The ALS Association


    Larry Falivena, has no relevant financial relationships.


  • Meg Monday

    Senior Director, Content Development, Medscape, LLC 


    Meg Monday has no relevant financial relationships. 

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape and ALS Association.


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Early Diagnosis and the Need for Novel Therapeutics in ALS: Highlights from a Recent Symposium

Authors: Suma Babu, MBBS, MPH; Neil M. Thakur, PhD; Richard S. Bedlack, MD, PhD; Zachary Simmons, MD; Larry FalivenaFaculty and Disclosures

CME / ABIM MOC Released: 10/20/2022

Valid for credit through: 10/20/2023, 11:59 PM EST


A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print